Neuropathic pain

Neuropathic Pain

Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory system, resulting in symptoms that include burning, stabbing, shooting, or electric shock-like sensations, which substantially differentiate it from nociceptive pain. Neuropathic pain is not a single disease, but a syndrome caused by an array of different diseases and lesions, with common subtypes such as diabetic peripheral neuropathy, post-herpetic neuralgia, and chemotherapy-induced neuropathic pain.

Full Disease Coverage Report

  • Neuropathic Pain: Full Disease Coverage
    $22000
    Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory system, resulting in symptoms that include burning, stabbing, shooting, or electric shock-like sensations, which substantially differentiate it from nociceptive pain.

Or Buy as separate elements

  • Neuropathic Pain: Epidemiology Report
    $1769
    This epidemiologic analysis uses robust, country-specific data sources and primary research data to estimate and forecast total prevalent cases of neuropathic pain in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK) between 2017 and 2037.

  • Neuropathic Pain: Forecast Report
    $9000
    Datamonitor Healthcare uses a patient-based approach to size the commercial potential of the neuropathic pain market across the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK). This analysis contains an assessment of key neuropathic pain therapies on the market and in the late-phase pipeline, a discussion of neuropathic pain market dynamics, and a 10-year patient-based sales forecast.

  • Neuropathic Pain: Marketed Drugs
    $4077
    In-depth analysis of key marketed drugs for neuropathic pain in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK), including new clinical data and a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

  • Neuropathic Pain: Pipeline Report
    $3538
    In-depth analysis of key pipeline products for neuropathic pain in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK), including new clinical data and a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

  • Neuropathic Pain: Treatment Report
    $3615
    Datamonitor Healthcare conducted a survey of 220 primary care physicians and specialists in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK) to gain insight into neuropathic pain diagnosis, patient segmentation, current and future prescribing patterns, factors influencing decision-making, and key treatment challenges.